Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
The Qnexa FDA approval is currently pending and the pharmaceutical company behind Qnexa (now called Qsymia), Vivus is revising their safety precautions for the FDA. Qnexa / Qsymia is not available for prescription now but if approved by the FDA, you could be prescribed and be able to buy Qnexa soon. The FDA will most likely give their final approval of it quite possibly July of this year 2012.